suwandi-tan
A devastating measles epidemic in Bangladesh has claimed more than 1,000 lives since mid-March, exposing critical vulnerabilities in the country’s healthcare infrastructure even as authorities carry out an unprecedented emergency vaccination drive. Despite administering nearly 20 million doses to young children across the nation over recent months, public health officials continue to struggle against a fast-moving outbreak that has overwhelmed specialized medical facilities.
The tragedy of the outbreak is reflected in the loss of one-year-old Saif Hasan, who died shortly after being placed in intensive care at Dhaka’s Infectious Diseases Hospital on August 27. The infant, brought from the southern district of Shariatpur, had developed a severe fever and telltale rashes just days after receiving his initial measles-rubella immunization. His sudden deterioration left his family questioning whether the inoculation itself had caused his rapid decline.
Medical specialists at the facility explained that the child had contracted the wild virus before the vaccine had adequate time to stimulate protective antibodies. Dr. Shrebash Paul, a junior consultant at the hospital, noted that the infant had been battling an existing respiratory ailment, which was fatally worsened when the measles infection took hold. Such cases illustrate the precarious race between rapid disease transmission and late immunization efforts.
The severity of the current crisis stands in sharp contrast to the previous year, when Bangladesh appeared on the verge of eliminating the disease. In 2025, the country documented only 132 total measles infections and recorded zero fatalities. The sudden deterioration into a nationwide crisis has caught both health systems and vulnerable communities off guard.
Official surveillance figures compiled through September 9 indicate that 1,009 people have died from the disease since March 15. The toll includes 100 laboratory-confirmed measles fatalities alongside 909 deaths classified by medical authorities as suspected measles cases. Concurrently, government statistics show that 19.75 million children have received shots under the emergency response, seemingly surpassing the initial campaign goal of reaching 18 million youngsters.
Epidemiologists point out that this statistical accomplishment masks deep structural flaws in how the epidemic has been managed. While macro-level figures suggest widespread success, the emergency drive was undermined from the outset by flawed baseline estimates and the persistence of substantial pockets of unprotected children who remain exposed to the highly contagious pathogen.
A primary shortcoming lies in the calculation of the target population. When the nationwide measles-rubella drive was initiated on April 20 for children between six months and five years of age, officials established a target of roughly 18 million recipients. However, when the government conducted a separate Vitamin A supplementation initiative for the identical age demographic just two months later on June 28, it set a target of 24 million children.
This discrepancy of approximately six million eligible children highlights why achieving the initial vaccination goal failed to halt viral transmission. Mushtuq Hussain, a former principal scientific officer at Bangladesh’s Institute of Epidemiology, Disease Control and Research, pointed out that the original campaign targets relied on population estimates that significantly undercounted the number of children at risk.
The nation of roughly 178 million people had spent years building towards disease elimination before systemic disruptions reversed hard-won progress. According to Bangladesh’s 2023 Coverage Evaluation Survey, first-dose coverage for the measles-rubella vaccine dropped from 88.6 percent in 2019 to 86 percent in 2023. Protection from the vital second dose suffered an even steeper drop, declining from 89 percent down to 80.7 percent over the same four-year period.
Public health specialists attribute this gradual decline to a combination of widespread healthcare disruptions during the COVID-19 pandemic, expanding vaccine hesitancy, and the proliferation of medical misinformation cited by agencies such as UNICEF. Furthermore, Bangladesh had not conducted a nationwide supplementary immunization campaign since the drive that concluded in January 2021, allowing a dangerous pool of unvaccinated children to accumulate.
The vulnerability was exacerbated by political instability following the July 2024 uprising that resulted in the ouster of former Prime Minister Sheikh Hasina. The subsequent administrative changes led to severe disruptions in routine healthcare logistics and procurement delays, which created acute vaccine shortages throughout 2024 and 2025.
Infections began to rise sharply in January 2026, quickly escalating into an uncontrollable surge by March. The government formally notified the World Health Organization of a nationwide outbreak on April 4. Within weeks, the virus had spread across 58 of Bangladesh’s 64 administrative districts, prompting initial emergency inoculations in high-risk zones on April 5 before expanding nationally later that month.
Because measles is among the most transmissible infectious diseases known, stopping community spread requires maintaining an overall population immunity level of at least 95 percent. When immunity levels fall below that threshold, localized chains of transmission can persist and ignite wider flare-ups.
Hussain emphasized that broad national averages often conceal severe regional immunity gaps, particularly among marginalized, mobile, and difficult-to-reach populations. He argued that public health interventions must maintain equity by ensuring that every single community meets the 95 percent protection threshold rather than relying solely on aggregate national statistics.
Another senior epidemiologist with extensive operational experience in the national immunization framework noted that health authorities must conduct granular analyses of caseloads based on age, geographical location, and past immunization records. Without micro-targeted interventions designed to reach specific clusters of unimmunized children, the virus will continue to circulate even if overall national infection counts begin to drop.
On the front lines of the crisis, clinicians continue to witness the direct consequences of these persistent coverage gaps. At Dhaka’s Infectious Diseases Hospital, Dr. Paul reported that the overwhelming majority of measles patients admitted to wards and intensive care units continue to be children who have never received a single dose of the vaccine.
Comments (0)